Characteristic | Number of studies (n) | Percentage of studies (%) |
---|---|---|
Sub-Saharan country | ||
 South Africa | 18 | 29.5 |
 Nigeria | 5 | 8.2 |
 Kenya | 4 | 6.6 |
 Zambia | 4 | 6.6 |
 Rwanda | 4 | 6.6 |
 Uganda | 4 | 6.6 |
 Ethiopia | 3 | 4.9 |
 Cameroon | 3 | 4.9 |
 Tanzania | 2 | 3.3 |
 Malawi | 2 | 3.3 |
 Sierra Leone | 2 | 3.3 |
 Liberia | 2 | 3.3 |
 Mali | 1 | 1.6 |
 Sudan | 1 | 1.6 |
 Eritrea | 1 | 1.6 |
 Democratic Republic of the Congo | 1 | 1.6 |
 Guinea | 1 | 1.6 |
 Swaziland | 1 | 1.6 |
 Zimbabwe | 1 | 1.6 |
 Botswana | 1 | 1.6 |
Publication date | ||
 1998–2003 | 3 | 4.9 |
 2004–2009 | 17 | 27.9 |
 2010–2015 | 21 | 34.4 |
 2015+ | 20 | 32.8 |
Study design | ||
 RCT | 7 | 11.5 |
 Quasi-experimental | 22 | 36.1 |
 Cohort | 13 | 21.3 |
 Cross-sectional | 12 | 19.7 |
 Mixed methods | 3 | 4.9 |
 Qualitative | 3 | 4.9 |
 Multi-modal | 1 | 1.6 |
Healthcare Workers | ||
 Healthcare workers (physicians, nurses, laboratory techs, etc.) | 47 | 77.0 |
 Nurses only | 14 | 22.9 |
Diseases/infections | ||
 HIV | 24 | 39.3 |
 TB | 6 | 9.8 |
 Ebola | 6 | 9.8 |
 Multiple diseases | 3 | 4.9 |
 Malaria | 2 | 3.3 |
 CLABSI | 1 | 1.6 |
 VAP | 1 | 1.6 |
 SSI | 1 | 1.6 |
 Bloodborne (non- CLABSI) | 1 | 1.6 |
 STIs (non-HIV) | 1 | 1.6 |
 None (hand hygiene, disinfection focused) | 14 | 23.0 |
Evidence-based practices | ||
 Standard Precautions | 21 | 34.4 |
  Multiple SP | 11 | 18.0 |
  Hand hygiene | 8 | 13.1 |
  Disinfection | 1 | 1.6 |
  Waste management | 1 | 1.6 |
 Transmission-based precautions | 4 | 6.6 |
  PPE | 1 | 1.6 |
  Isolation/quarantine | 1 | 1.6 |
  Immunization | 1 | 1.6 |
  Post-exposure prophylaxis | 1 | 1.6 |
 Administrative precautions | 36 | 59.0 |
  Treatment | 21 | 34.4 |
  Screening/surveillance | 11 | 18.0 |
  Diagnosis | 4 | 6.6 |
 Quality assessment score | ||
  MAStARI 4 | 1 | 1.6 |
  MAStARI 5 | 19 | 31.1 |
  MAStARI 6 | 10 | 16.4 |
  MAStARI 7 | 16 | 26.2 |
  MAStARI 8 | 5 | 8.2 |
  MAStARI 9 | 3 | 4.9 |
  MAStARI 10 | 1 | 1.6 |
  MAStARI 11 | 2 | 3.3 |
  QARI 5 | 1 | 1.6 |
  QARI 6 | 0 | 0.0 |
  QARI 7 | 1 | 1.6 |
  QARI 8 | 2 | 3.3 |
  MMAT 0% | 0 | 0.0 |
  MMAT 50% | 2 | 3.3 |
  MMAT 75% | 1 | 1.6 |
  MMAT 100% | 0 | 0.0 |